Insider Stock Trading History of Ashton William


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ashton William since year 2005. The trader's CIK number is 1474553. At the time of this reporting, Ashton William is the Director of Recro Pharma, Inc. . (stock ticker symbol REPH). See this page for all insider trading activities at Recro Pharma, Inc. .

Note that in the past Ashton William also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Ashton William since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-05-12 REPH Recro Pharma, Inc. Option Ex 13,274 .00 0
2015-03-12 SCMP Sucampo Pharmaceuticals, Inc. Option Ex 55,762 7.71 429,925
2015-03-11 SCMP Sucampo Pharmaceuticals, Inc. Option Ex 74,004 5.02 371,204
2015-03-12 SCMP Sucampo Pharmaceuticals, Inc. Sale 55,762 17.55 978,623
2015-03-11 SCMP Sucampo Pharmaceuticals, Inc. Sale 74,004 17.32 1,281,749

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ashton William (Director of Recro Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.